TMO
Thermo FisherstockTMO · 90-day price history
Prediction models
All predictions →Trend follower
Horizon: 1 week
Accuracy data accumulates as predictions are evaluated over time.
How this worksHide explanation
Compares a 10-day vs 50-day moving average. When the short-term average rises above the long-term average, the trend is up.
Not financial advice. Past accuracy does not guarantee future results.
Momentum
Horizon: 1 week
Accuracy data accumulates as predictions are evaluated over time.
How this worksHide explanation
Uses RSI (a gauge of recent buying/selling intensity) and 5-day rate-of-change to judge whether the stock has been pushed too far in one direction.
Not financial advice. Past accuracy does not guarantee future results.
Statistical trend
Horizon: 1 month
Accuracy data accumulates as predictions are evaluated over time.
How this worksHide explanation
Fits a trend line through the last 60 days of prices and measures how far the current price has strayed from it.
Not financial advice. Past accuracy does not guarantee future results.
Multi-factor + news
Horizon: 1 week
Accuracy data accumulates as predictions are evaluated over time.
How this worksHide explanation
Combines trend (25%), momentum (25%), volume (15%), and AI-analysed news sentiment (35%) from your trusted sources into one score.
Not financial advice. Past accuracy does not guarantee future results.
Bull / Bear thesis
AI analysisBenefits from multiple high-growth biotech markets
Advanced bioreactor market growing at 10.9% CAGR to $11.8B, transcriptome sequencing at 7.3% CAGR, organoid intelligence at 27.1% CAGR
YahooPositioned as infrastructure supplier to entire biotech sector
Thermo Fisher's equipment and services benefit from all three major growth markets simultaneously
YahooDividend champion status provides income
Included in dividend watchlist, indicating long track record of shareholder returns
SeekingAlphaMarkets still in early growth phases
Organoid intelligence market only $78.6M in 2026 despite 27% CAGR, indicating long ramp-up ahead
YahooStock down slightly suggesting profit-taking
Down 0.41% despite positive market tailwinds
Price actionValuation may already price in growth
At $603 per share, market appears to have strong expectations built in
Price actionAI-generated from recent news and price action. Not financial advice. Educational only.
Seasonality
~5y of historyAvg return by month · %
This month historically: -3.8% on average, up 20% of 5 years.
Avg return by weekday · %
Historical pattern only — seasonality is not a prediction and often breaks.
Recent news
Yahoo · Sep 11
Advanced bioreactors are critical to producing modern biologics; the 10.9% CAGR growth to $11.8B by 2036 benefits Thermo Fisher's equipment and services business.
Yahoo · Sep 10
The transcriptome sequencing market growing at 7.3% CAGR to $11.8B by 2035 represents a large opportunity for Thermo Fisher's sequencing consumables and instruments.
Yahoo · Sep 10
Organoid intelligence is an emerging $78.6M market growing at 27.1% CAGR; Thermo Fisher's cell culture and bioreactor capabilities position it to capture significant value.
AI research companion
AI Research Companion
Loading…
Ready to paper trade TMO?
Switch to Portfolio mode to buy and sell with $100k of simulated funds.